Pharmaceutical blister packaging

In Europe, 85% of solid pharmaceuticals are packaged in blister packaging, compared with less than 20% of solid pharmaceuticals in the United States. However, as manufacturers and consumers become aware of the benefits of blister packaging, the acceptance of blister packaging in the United States is also increasing. This article will briefly introduce blister packaging materials and typical blister structures. Packaging is one of the largest components of global industry, valued at $280 billion. Among them, consumer health packaging accounted for 4% (USD 11.2 billion). As drug manufacturers enter the 21st century, they face many challenges, and packaging can help them meet some of those needs.

A decade ago, many pharmaceutical companies tended not to take packaging seriously and viewed it simply as the final step in production. But now pharmaceutical companies must consider packaging much earlier in the development process. Pharmaceutical packaging is quickly becoming an essential part of the drug delivery system and a core element of the marketing mix, allowing manufacturers to differentiate their products from competitors. The demand for pharmaceutical packaging is increasing and will continue to increase as pharmaceutical companies rely more on packaging and labeling as a medium to protect and promote their products, improve patient compliance, and comply with new regulations.

sale02@sdzlplastic.com

www.sdzlplastic.com